
Flibanserin tablet
Form: Tablet
Strength: 100 mg
Reference Brands: Addyi(US)
Category: Sexual Wellness
Flibanserin tablets, marketed as Addyi, are approved in the US by the FDA for the treatment of premenopausal women with hypoactive sexual desire disorder (HSDD). Regulatory requirements include a comprehensive dossier with clinical efficacy, safety data, manufacturing quality, and pharmacovigilance plans. In the US, the FDA conducts detailed review processes, while the EU’s EMA assesses compliance with regional safety and quality standards—though approval in Europe remains pending or varies by country. For guidance on dossier preparation, regulatory pathways, and market access strategies, visit PharmaTradz. Ensuring thorough compliance supports timely approval, safe use, and broader global availability, improving quality of life for women worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Related Products
Shilajit Capsules/Tablet
Strength: 300 mg–600 mg per dose.
Form: Tablet/ Capsules
Reference Brands: Pure Himalayan Shilajit Resin(US)
View Details Get EnquiryTribulus Terrestris Capsules
Strength: 500-750 mg
Form: Capsules
Reference Brands: Optimum Nutrition Tribulus(US)
View Details Get EnquiryHorny Goat Weed Capsules
Strength: 500–700 mg
Form: Capsules
Reference Brands: NOW Foods Horny Goat Weed(US)
View Details Get EnquiryAshwagandha Capsules
Strength: 300-600 mg
Form: Capsules
Reference Brands: NOW Foods Ashwagandha
View Details Get Enquiry